A detailed history of Peachtree Investment Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Peachtree Investment Partners, LLC holds 4,802 shares of NVO stock, worth $504,498. This represents 0.22% of its overall portfolio holdings.

Number of Shares
4,802
Previous 10,179 52.82%
Holding current value
$504,498
Previous $1.45 Million 60.67%
% of portfolio
0.22%
Previous 0.57%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $640,239 - $781,923
-5,377 Reduced 52.82%
4,802 $571,000
Q2 2024

Aug 12, 2024

BUY
$122.71 - $146.91 $320,641 - $383,875
2,613 Added 34.54%
10,179 $1.45 Million
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $546,492 - $727,443
5,352 Added 241.73%
7,566 $971,000
Q4 2023

Feb 12, 2024

SELL
$87.78 - $105.45 $100,771 - $121,056
-1,148 Reduced 34.15%
2,214 $229,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $10,821 - $23,745
119 Added 3.67%
3,362 $305,000
Q2 2023

Aug 14, 2023

SELL
$155.98 - $172.65 $874,579 - $968,048
-5,607 Reduced 63.36%
3,243 $524,000
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $778,026 - $935,584
5,879 Added 197.88%
8,850 $1.41 Million
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $304,676 - $402,065
2,971 New
2,971 $402,000
Q2 2022

Aug 16, 2022

SELL
$103.24 - $121.81 $280,812 - $331,323
-2,720 Closed
0 $0
Q1 2022

Jun 08, 2022

BUY
$93.1 - $112.54 $67,032 - $81,028
720 Added 36.0%
2,720 $302,000
Q4 2021

Feb 11, 2022

BUY
$95.88 - $117.08 $191,760 - $234,160
2,000 New
2,000 $224,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Peachtree Investment Partners, LLC Portfolio

Follow Peachtree Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peachtree Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peachtree Investment Partners, LLC with notifications on news.